
INMODE LTDINARY SHARES
Share · IL0011595993 · INMD (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of INMODE LTDINARY SHARES
No Price
29.04.2026 05:27
Current Prices from INMODE LTDINARY SHARES
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
Quotrix |
IMLRSI93.DUSD
|
EUR
|
29.04.2026 05:27
|
12,16 EUR
| - |
NASDAQ |
INMD
|
USD
|
28.04.2026 20:00
|
14,21 USD
| -0,10 USD
-0,70 %
|
IEX |
INMD
|
USD
|
28.04.2026 19:59
|
14,21 USD
| -0,10 USD
-0,70 %
|
Düsseldorf |
IMLRSI93.DUSB
|
EUR
|
28.04.2026 17:30
|
12,06 EUR
| - |
Company Profile for INMODE LTDINARY SHARES Share
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
Company Data
Name INMODE LTDINARY SHARES
Company InMode Ltd.
Symbol INMD
Website
https://www.inmodemd.com
Primary Exchange
NASDAQ
NASDAQ
ISIN IL0011595993
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Moshe Mizrahy
Market Capitalization 900 Mio
Country Israel
Currency USD
Employees 0,6 T
Address Tavor Building, 2069206 Yokne'am
IPO Date 2019-08-08
Stock Splits
| Date | Split |
|---|---|
| 01.10.2021 | 2:1 |
| 30.09.2021 | 2:1 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Düsseldorf | IMLRSI93.DUSB |
| Frankfurt | 154.F |
| NASDAQ | INMD |
| Quotrix | IMLRSI93.DUSD |
More Shares
Investors who hold INMODE LTDINARY SHARES also have the following shares in their portfolio:


